Expression of HNFs and C/EBPα is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes
Open Access
- 1 September 2003
- journal article
- Published by Wiley in Cancer Science
- Vol. 94 (9) , 757-763
- https://doi.org/10.1111/j.1349-7006.2003.tb01515.x
Abstract
Objective assessment of the differentiation grade of hepatocellular carcinomas (HCCs) is important for evaluation of the pathological diagnosis, prognosis and therapeutic treatment. Differentiation of hepatocytes is reflected by their expression of hepatic functional proteins in the mouse embryo, and liver‐enriched transcription factors (LETFs) have been shown to regulate hepatic functional genes strictly. Previous reports demonstrated that the level of LETF expression is altered in HCC or preneoplastic nodules compared with noncancerous tissues. Therefore, LETF expression levels might be useful as a measure of HCC maturation. In this study, to clarify the correlation between the expression of LETFs and the differentiation grade of HCCs, we performed a quantitative analysis of the mRNA expressions of HNFs and C/EBPα using real‐time reverse‐transcription PCR and immunocytochemical analysis for hepatic functional proteins in twelve cell lines. Furthermore, we examined orthotopic transplantations of the HCC cell lines in C.B‐17/Icrj‐scid/scid mice and characterized the histologic and cytologic differentiation of the tumors that developed. Our results showed that comprehensive expressions of HNF‐3β, HNF‐4α, HNF‐1α, and C/EBPα were specific to HCCs with well‐differentiated function and morphology. Furthermore, among these four transcription factors, HNF‐4α and HNF‐1α expressions showed synchronism and had a close relation with HCC differentiation. These in vitro results were confirmed in tumors developed in SCID mice in vivo. These findings suggested that HNF‐4α and HNF‐1α are useful markers to assess the degree of HCC differentiation, which we suggest could be evaluated objectively by the quantitative analysis of HNFs and C/EBPα in HCCs.This publication has 20 references indexed in Scilit:
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Prognostic features and survival of hepatocellular carcinoma in ItalyEuropean Journal Of Cancer, 2001
- Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor IBiochemical Journal, 1999
- Phenotypic characterization of rat hepatoma cell lines and lineage-specific regulation of gene expression by differentiation agentsDifferentiation, 1998
- Expression of HNF-1α and HNF-1β in various histological differentiations of hepatocellular carcinomaThe Journal of Pathology, 1998
- Expression of CD44 in human hepatocellular carcinoma cell lines*1Hepatology, 1995
- Characterization of High‐Molecular‐Mass Forms of Basic Fibroblast Growth Factor Produced by Hepatocellular Carcinoma Cells: Possible Involvement of Basic Fibroblast Growth Factor in HepatocarcinogenesisJapanese Journal of Cancer Research, 1991
- Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes.Molecular and Cellular Biology, 1989
- Interaction of a Liver-Specific Nuclear Factor with the Fibrinogen and α 1 -Antitrypsin PromotersScience, 1987
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979